Evidence map›Paper›PMID 32718084›Full record

ArticleMarine drugs2020

13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity Against Oral Cancer Cells Through the Interruption of the Keap1/Nrf2/p62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts.

Yi-Chang Liu, Bo-Rong Peng, Kai-Cheng Hsu, Mohamed El-Shazly, Shou-Ping Shih, Tony Eight Lin, Fu-Wen Kuo, Yi-Cheng Chou, Hung-Yu Lin, Mei-Chin Lu

Open access · goldAbstract readComparative Study
In one paragraph

Article in Marine drugs, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 29 citations in OpenAlex.

  1. Antioxidant Peptides fromMarine drugs · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. 6-Biomedicines · 2024
    Article
  8. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Article
  11. International journal of molecular sciences · 2023
    Article
  12. Article
  13. Article
  14. Marine SpongePharmaceuticals (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Methanol Extract ofAntioxidants (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Methanol Extract ofAntioxidants (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Yi-Chang LiuDivision of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Bo-Rong PengDoctoral Degree Program in Marine Biotechnology, National Sun Yat-Sen University (NSYSU), 70 Lien-Hai Road, Kaohsiung 80424, Taiwan.
Kai-Cheng HsuGraduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 106, Taiwan.
Mohamed El-ShazlyDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Organization of African Unity Street, Abassia, Cairo 11566, Egypt.
Shou-Ping ShihDoctoral Degree Program in Marine Biotechnology, National Sun Yat-Sen University (NSYSU), 70 Lien-Hai Road, Kaohsiung 80424, Taiwan.
Tony Eight LinPh.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 106, Taiwan.
Fu-Wen KuoGraduate Institute of Marine Biology, National Dong Hwa University, Pingtung 944, Taiwan.
Yi-Cheng ChouGraduate Institute of Marine Biology, National Dong Hwa University, Pingtung 944, Taiwan.
Hung-Yu LinSchool of Medicine, College of Medicine, I-SHOU University; Division of Urology, Department of Surgery; E-Da Cancer & E-Da Hospital, Kaohsiung 824, Taiwan.
Mei-Chin LuGraduate Institute of Marine Biology, National Dong Hwa University, Pingtung 944, Taiwan.
National Dong Hwa University · TWNational Sun Yat-sen University · TWTaipei Medical University · TWAin Shams University · EGE-Da Hospital · TWKaohsiung Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

13-Acetoxysarcocrassolide (13-AC), a marine cytotoxic product isolated from the alcyonacean coral

Indexed as

AnimalsAntineoplastic AgentsApoptosisCell ProliferationDiterpenesHCT116 CellsHeLa CellsHumansKelch-Like ECH-Associated Protein 1MaleMCF-7 CellsMembrane Potential, MitochondrialMice, NudeMouth NeoplasmsNF-E2-Related Factor 2Reactive Oxygen Species13-acetoxysarcocrassolideAntineoplastic AgentsDiterpenesKEAP1 protein, humanKelch-Like ECH-Associated Protein 1NFE2L2 protein, humanNF-E2-Related Factor 2Reactive Oxygen SpeciesSequestosome-1 ProteinSQSTM1 protein, human13-AcetoxysarcocrassolideapoptosisKeap1/Nrf2/p62/SQSTM1oral canceroxidative stressreactive oxygen species

Identifiers

PMID32718084
PMCPMC7459766
OpenAlexW3044962284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.